Andrea Iannello

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies.

Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies.

Journal: Leukemia

Published: October 08, 2025

Complementary approaches define the metabolic features that accompany Richter syndrome transformation.

Complementary approaches define the metabolic features that accompany Richter syndrome transformation.

Journal: Cellular and molecular life sciences : CMLS

Published: November 14, 2024

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

Journal: Haematologica

Published: October 10, 2022

Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome.

Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome.

Journal: Blood

Published: March 07, 2022

Novel Approaches for the Treatment of Patients with Richter's Syndrome.

Novel Approaches for the Treatment of Patients with Richter's Syndrome.

Journal: Current treatment options in oncology

Published: February 23, 2022

Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targets.

Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targets.

Journal: Cancer letters

Published: January 19, 2022

Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models.

Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models.

Journal: Blood

Published: December 01, 2020

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

Journal: Blood

Published: July 27, 2020

Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.

Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.

Journal: International journal of molecular sciences

Published: January 01, 2020

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.

Journal: Disease models & mechanisms

Published: November 25, 2019

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Journal: Frontiers in immunology

Published: September 10, 2018

Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Journal: Oncoimmunology

Published: June 09, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026